Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Waheed Website

Abdul A. Waheed, Ph.D.

Selected Publications

1)  Zhang H, Curreli F, Waheed A, Mercredi P, Mehta M, Bhargava P, Scacalossi D, Tong X, Lee S, Cooper A, Summers M, Freed E, Debnath A.
Dual-acting stapled peptides target both HIV-1 entry and assembly.
Retrovirology. 10: 136, 2013.
Full Text Article. [Journal]
2)  Waheed AA, Ablan SD, Roser JD, Sowder RC, Schaffner CP, Chertova E, Freed EO.
HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
Proc. Natl. Acad. Sci. U.S.A. 104: 8467-71, 2007.
3)  Waheed AA, Ablan SD, Mankowski MK, Cummins JE, Ptak RG, Schaffner CP, Freed EO.
Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants.
J. Biol. Chem. 281: 28699-711, 2006.
4)  Johnson EN, Seasholtz TM, Waheed AA, Kreutz B, Suzuki N, Kozasa T, Jones TL, Brown JH, Druey KM.
RGS16 inhibits signalling through the G alpha 13-Rho axis.
Nat. Cell Biol. 5: 1095-103, 2003.
5)  Waheed AA, Shimada Y, Heijnen HF, Nakamura M, Inomata M, Hayashi M, Iwashita S, Slot JW, Ohno-Iwashita Y.
Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
Proc. Natl. Acad. Sci. U.S.A. 98: 4926-31, 2001.
6)  Daniels SI, Soule EE, Davidoff KS, Bernbaum JG, Hu D, Maeda K, Stahl SJ, Naiman NE, Waheed AA, Freed EO, Wingfield P, Yarchoan R, Davis DA.
Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide.
FASEB J. 28: 106-16, 2014.
7)  Waheed AA, Freed EO.
HIV Type 1 Gag as a Target for Antiviral Therapy.
AIDS Res. Hum. Retroviruses. 28: 54-75, 2012.
8)  Waheed AA, Brass AL, Gummuluru S, Tachedjian G.
Host-pathogen interactions of retroviruses.
Mol Biol Int. 2012: 648512, 2012.
9)  Zhang H, Curreli F, Zhang X, Bhattacharya S, Waheed AA, Cooper A, Cowburn D, Freed EO, Debnath AK.
Antiviral activity of alpha-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Retrovirology. 8: 28, 2011.
10)  Kim SE, Liu F, Im YJ, Stephen AG, Fivash MJ, Waheed AA, Freed EO, Fisher RJ, Hurley JH, Burke TR.
Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands.
ACS medicinal chemistry letters. 2: 337-341, 2011.
Click Here to View Expanded Bibliography.

This page was last updated on 3/28/2014.